US Stock MarketDetailed Quotes
XBIOW Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com)
- 17.5400
- 0.00000.00%
Close Jul 18 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open17.5400Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares20.500052wk High0.00P/B0Float Cap1.120052wk Low--Dividend TTM0Shs Float23.1600Historical High--Div YieldTTM0.00%Amplitude0.0001Historical Low--Avg Price1Lot Size
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5.16%-1.16M | 11.46%-4.11M | -5.61%-793.03K | 12.01%-949.63K | -74.11%-1.27M | 47.19%-1.1M | 1.93%-4.65M | 48.52%-750.91K | -4.44%-1.08M | -0.29%-728.9K |
| Net income from continuing operations | -39.53%-1.2M | 36.90%-4.13M | 20.98%-1.17M | -31.29%-1.06M | 60.67%-1.05M | 46.25%-856.55K | -16.07%-6.55M | 19.50%-1.48M | 40.48%-804.02K | -141.46%-2.67M |
| Depreciation and amortization | ---- | --0 | --0 | --0 | ---- | ---- | -23.78%27.04K | --0 | -11.98%7.96K | 9.89%9.61K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | --1.79M | --488.75K | --0 | ---- |
| Change In working capital | 86.88%-41.31K | 38.43%-262.73K | 144.63%303.9K | 108.48%35.66K | -158.35%-287.55K | 49.49%-314.74K | -192.52%-426.69K | -52.33%124.23K | -313.12%-420.57K | 88.67%492.81K |
| -Change in prepaid assets | 116.16%51.79K | 53.99%-47.73K | 469.94%876.73K | -232.75%-161.53K | -261.48%-442.5K | -22.10%-320.45K | -136.27%-103.74K | -168.00%-236.99K | 291.48%121.67K | 147.34%274.02K |
| -Change in payables and accrued expense | 57.06%-93.09K | 24.25%-263.57K | -1,261.14%-258.91K | 186.36%197.18K | -93.08%14.95K | 39.42%-216.79K | -176.12%-347.95K | -92.56%22.3K | -247.00%-228.33K | 43.55%215.92K |
| -Change in other current assets | --0 | 94.32%48.58K | -192.62%-313.92K | --0 | 4,776.35%140K | 7,849.91%222.5K | 108.87%25K | 187.46%338.92K | ---313.92K | --2.87K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -5.16%-1.16M | 11.46%-4.11M | -5.61%-793.03K | 12.01%-949.63K | -74.11%-1.27M | 47.19%-1.1M | 1.93%-4.65M | 48.52%-750.91K | -4.44%-1.08M | -0.29%-728.9K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | -500K | 0 | 0 | ||||
| Net intangibles purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | ---500K | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | --0 | ---- | ---- | ---500K | --0 | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -31.41%8.98M | -28.21%13.1M | -29.41%9.78M | -28.15%10.73M | -25.76%11.99M | -28.21%13.1M | 58.26%18.24M | -29.71%13.85M | 60.83%14.93M | 61.43%16.16M |
| Current changes in cash | -5.16%-1.16M | 20.06%-4.11M | -5.61%-793.03K | 12.01%-949.63K | -3.27%-1.27M | 47.19%-1.1M | -176.63%-5.15M | 48.52%-750.91K | -110.36%-1.08M | -69.08%-1.23M |
| End cash Position | -34.77%7.82M | -31.41%8.98M | -31.41%8.98M | -29.41%9.78M | -28.15%10.73M | -25.76%11.99M | -28.21%13.1M | -28.21%13.1M | -29.71%13.85M | 60.83%14.93M |
| Free cash flow | -5.16%-1.16M | 20.06%-4.11M | -5.61%-793.03K | 12.01%-949.63K | -3.27%-1.27M | 47.19%-1.1M | -8.63%-5.15M | 48.52%-750.91K | -4.44%-1.08M | -69.08%-1.23M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data